Medicago and GSK announce the approval by Health Canada of COVIFENZ®, an Adjuvanted Plant-Based COVID-19 VaccineA vaccine manufactured in plants and developed in CanadaQuebec City, London, February 24, 2022 – Medicago, a biopharmaceutical company headquartered in Quebec City, and GlaxoSmithKline (GSK) toda.